BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, Miyazaki I. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology. 1994;106:720-727. [PMID: 8119543 DOI: 10.1016/0016-5085(94)90707-2] [Cited by in Crossref: 283] [Cited by in F6Publishing: 259] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Bertolotto M, Pozzato G, Crocè LS, Nascimben F, Gasparini C, Cova MA, Tiribelli C. Blood flow changes in hepatocellular carcinoma after the administration of thalidomide assessed by reperfusion kinetics during microbubble infusion: preliminary results. Invest Radiol. 2006;41:15-21. [PMID: 16355035 DOI: 10.1097/01.rli.0000188363.93670.45] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
2 Chevret S, Trinchet JC, Mathieu D, Rached AA, Beaugrand M, Chastang C. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d’Etude et de Traitement du Carcinome Hépatocellulaire. J Hepatol. 1999;31:133-141. [PMID: 10424293 DOI: 10.1016/s0168-8278(99)80173-1] [Cited by in Crossref: 329] [Cited by in F6Publishing: 112] [Article Influence: 15.0] [Reference Citation Analysis]
3 Liu P, Qiu BA, Bai G, Bai HW, Xia NX, Yang YX, Zhu JY, An Y, Hu B. Choice of approach for hepatectomy for hepatocellular carcinoma located in the caudate lobe: isolated or combined lobectomy? World J Gastroenterol. 2012;18:3904-3909. [PMID: 22876044 DOI: 10.3748/wjg.v18.i29.3904] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yamamoto Y, Ikoma H, Morimura R, Shoda K, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol. 2015;21:246-253. [PMID: 25574098 DOI: 10.3748/wjg.v21.i1.246] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
5 Peck-Radosavljevic M, Pidlich J, Bergmann M, Ferenci P, Seelos C, Wichlas M, Lipinski E, Gnant M, Gangl A, Mühlbacher F. Preoperative TNM-classification is a better prognostic indicator for recurrence of hepatocellular carcinoma after liver transplantation than albumin mRNA in peripheral blood. Liver Transplant Oncology Group. J Hepatol. 1998;28:497-503. [PMID: 9551689 DOI: 10.1016/s0168-8278(98)80325-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
6 Tang SH, Yang DH, Huang W, Zhou M, Zhou HK, Lu XH, Ye G. Differential promoter usage for insulin-like growth factor-II gene in Chinese hepatocellular carcinoma with hepatitis B virus infection. Cancer Detect Prev. 2006;30:192-203. [PMID: 16697535 DOI: 10.1016/j.cdp.2005.12.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
7 Poon RT, Fan ST, Ng IO, Wong J. Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg. 2000;231:544-551. [PMID: 10749616 DOI: 10.1097/00000658-200004000-00014] [Cited by in Crossref: 250] [Cited by in F6Publishing: 232] [Article Influence: 11.9] [Reference Citation Analysis]
8 King KL, Hwang JJ, Chau GY, Tsay SH, Chi CW, Lee TG, Wu LH, Wu CW, Lui WY. Ki-67 expression as a prognostic marker in patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 1998;13:273-279. [PMID: 9570240 DOI: 10.1111/j.1440-1746.1998.01555.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
9 Kawamura Y, Ikeda K, Shindoh J, Kobayashi Y, Kasuya K, Fujiyama S, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Arase Y, Hashimoto M, Kumada H. No-touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection: No-touch ablation for HCC. Hepatol Res 2019;49:164-76. [DOI: 10.1111/hepr.13254] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
10 Kamada K, Kitamoto M, Aikata H, Kawakami Y, Kono H, Imamura M, Nakanishi T, Chayama K. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma. Am J Surg. 2002;184:284-290. [PMID: 12354601 DOI: 10.1016/s0002-9610(02)00933-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
11 Kawamura Y, Ikeda K, Fujiyama S, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y. Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodules. Hepatol Res. 2017;47:338-346. [PMID: 27249401 DOI: 10.1111/hepr.12754] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
12 Gouillat C, Manganas D, Saguier G, Duque-campos R, Berard P. Resection of hepatocellular carcinoma in cirrhotic patients: longterm results of a prospective study11No competing interests declared. Journal of the American College of Surgeons 1999;189:282-90. [DOI: 10.1016/s1072-7515(99)00142-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
13 Ohto M, Ito R, Soma N, Fukuda H, Shinohara Y, Sakamoto A, Kondo F. Contrast-enhanced 3D ultrasonography in minute hepatocellular carcinoma. J Med Ultrason (2001) 2011;38:3-12. [PMID: 27278332 DOI: 10.1007/s10396-010-0283-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Nanashima A, Nakayama T, Sumida Y, Abo T, Takeshita H, Shibata K, Hidaka S, Sawai T, Yasutake T, Nagayasu T. Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma. World J Gastroenterol. 2008;14:4915-4922. [PMID: 18756600 DOI: 10.3748/wjg.14.4915] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
15 Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, Franca A, Brú C, Navasa M, Ayuso MC. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology. 1998;27:1572-1577. [PMID: 9620329 DOI: 10.1002/hep.510270616] [Cited by in Crossref: 303] [Cited by in F6Publishing: 269] [Article Influence: 13.2] [Reference Citation Analysis]
16 Lin CY, Kee KM, Wang JH, Lee CM, Chen CL, Changchien CS, Hu TH, Cheng YF, Hsu HC, Wang CC. Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups. Liver Int. 2009;29:74-81. [PMID: 18331238 DOI: 10.1111/j.1478-3231.2008.01702.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
17 Katabami K, Mizuno H, Sano R, Saito Y, Ogura M, Itoh S, Tsuji T. Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region. Clin Exp Metastasis. 2005;22:539-548. [PMID: 16475024 DOI: 10.1007/s10585-005-5260-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
18 Vauthey JN, Pawlik TM, Lauwers GY, Nagorney DM, Roh MS, Curley SA, Poon RT, Belghiti J, Greene F, Michael Henderson J. Critical evaluation of the different staging systems for hepatocellular carcinoma (Br J Surg 2004; 91: 400-408). Br J Surg 2004;91:1072. [PMID: 15286973 DOI: 10.1002/bjs.4782] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
19 Philosophe B, Greig PD, Hemming AW, Cattral MS, Wanless I, Rasul I, Baxter N, Taylor BR, Langer B. Surgical management of hepatocellular carcinoma: resection or transplantation. J Gastrointest Surg. 1998;2:21-27. [PMID: 9841964 DOI: 10.1016/s1091-255x(98)80099-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
20 Thiesen AL. Hepatocellular Carcinoma in Adults. In: Sergi CM, editor. Liver Cancer. Exon Publications; 2021. pp. 39-54. [DOI: 10.36255/exonpublications.livercancer.2021.ch2] [Reference Citation Analysis]
21 Vauthey J, Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G, Lerut J, Chapman WC, Hemming AW, Neuhaus P. Outcomes of Liver Transplantation in 490 Patients with Hepatocellular Carcinoma: Validation of a Uniform Staging after Surgical Treatment. Journal of the American College of Surgeons 2007;204:1016-27. [DOI: 10.1016/j.jamcollsurg.2006.12.043] [Cited by in Crossref: 61] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
22 Lim JH, Choi D, Park CK, Lee WJ, Lim HK. Encapsulated hepatocellular carcinoma: CT-pathologic correlations. Eur Radiol 2006;16:2326-33. [PMID: 16547706 DOI: 10.1007/s00330-006-0203-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
23 Dilou N, Patouillard B, Audigier JC. [Staging systems in hepatocellular carcinoma]. Gastroenterol Clin Biol 2004;28:359-66. [PMID: 15146151 DOI: 10.1016/s0399-8320(04)94936-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
24 Bruix J, Bru C. Rationale for Non-surgical Interventional Treatment of Hepatocellular Carcinoma. In: Bartolozzi C, Lencioni R, editors. Liver Malignancies. Berlin: Springer Berlin Heidelberg; 1999. pp. 245-53. [DOI: 10.1007/978-3-642-58641-5_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
25 Sudo T, Utsunomiya T, Mimori K, Nagahara H, Ogawa K, Inoue H, Wakiyama S, Fujita H, Shirouzu K, Mori M. Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma. Br J Cancer. 2005;92:1754-1758. [PMID: 15856046 DOI: 10.1038/sj.bjc.6602531] [Cited by in Crossref: 163] [Cited by in F6Publishing: 151] [Article Influence: 10.2] [Reference Citation Analysis]
26 Kubo S, Hirohashi K, Yamazaki O, Matsuyama M, Tanaka H, Horii K, Shuto T, Yamamoto T, Kawai S, Wakasa K. Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B. World J Surg. 2002;26:555-560. [PMID: 12098045 DOI: 10.1007/s00268-001-0267-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
27 Burns JM, Greene FL. Controversies in staging of hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2005;12:456-62. [DOI: 10.1007/s00534-005-1030-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
28 Lee WC, Jeng LB, Chen MF. Estimation of prognosis after hepatectomy for hepatocellular carcinoma. Br J Surg. 2002;89:311-316. [PMID: 11872055 DOI: 10.1046/j.0007-1323.2001.02034.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 2.6] [Reference Citation Analysis]
29 DuBay D, Sandroussi C, Sandhu L, Cleary S, Guba M, Cattral MS, McGilvray I, Ghanekar A, Selzner M, Greig PD, Grant DR. Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion. Ann Surg. 2011;253:166-172. [PMID: 21294289 DOI: 10.1097/sla.0b013e31820508f1] [Cited by in Crossref: 170] [Cited by in F6Publishing: 87] [Article Influence: 17.0] [Reference Citation Analysis]
30 Wang D, Dou K, Xiang H, Song Z, Zhao Q, Chen Y, Li Y. Involvement of RhoA in progression of human hepatocellular carcinoma. J Gastroenterol Hepatol. 2007;22:1916-1920. [PMID: 15355639 DOI: 10.1111/j.1440-1746.2006.04534.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
31 Saab S, Ly D, Nieto J, Kanwal F, Lu D, Raman S, Amado R, Nuesse B, Durazo F, Han S. Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl. 2003;9:672-681. [PMID: 12827551 DOI: 10.1053/jlts.2003.50120] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
32 Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000;88:538-43. [DOI: 10.1002/(sici)1097-0142(20000201)88:3<538::aid-cncr7>3.0.co;2-h] [Cited by in Crossref: 148] [Cited by in F6Publishing: 51] [Article Influence: 7.0] [Reference Citation Analysis]
33 Hong SN, Lee SY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Rhee JC, Choi D, Lim HK, Lee KW, Joh JW. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol. 2005;39:247-252. [PMID: 15718869 DOI: 10.1097/01.mcg.0000152746.72149.31] [Cited by in Crossref: 181] [Cited by in F6Publishing: 159] [Article Influence: 11.3] [Reference Citation Analysis]
34 Ariizumi S, Yamamoto M, Ohtsubo T, Katsuragawa H, Katagiri S, Takasaki K. Step classification is useful for the determination of indications for systematized hepatectomy in hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2005;12:371-7. [DOI: 10.1007/s00534-005-1003-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
35 Choi Y, Choi Y, Choi CS, Lee YH. Diabetes mellitus increases the risk of intrahepatic recurrence of hepatocellular carcinoma after surgical resection. Tumori 2017;103:279-85. [PMID: 28085178 DOI: 10.5301/tj.5000594] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Ji SK, Cho YK, Ahn YS, Kim MY, Park YO, Kim JK, Kim WT. Multivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization. Korean J Radiol. 2008;9:534-540. [PMID: 19039270 DOI: 10.3348/kjr.2008.9.6.534] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
37 Kawamura Y, Ikeda K, Seko Y, Hosaka T, Kobayashi M, Saitoh S, Kumada H. Heterogeneous Type 4 Enhancement of Hepatocellular Carcinoma on Dynamic CT Is Associated With Tumor Recurrence After Radiofrequency Ablation. American Journal of Roentgenology 2011;197:W665-73. [DOI: 10.2214/ajr.11.6843] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
38 Jihye C, Jinsil S. Application of Radiotherapeutic Strategies in the BCLC-Defined Stages of Hepatocellular Carcinoma. Liver Cancer 2012;1:216-25. [PMID: 24159586 DOI: 10.1159/000343836] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
39 Wakai T, Shirai Y, Suda T, Yokoyama N, Sakata J, Cruz PV, Kawai H, Matsuda Y, Watanabe M, Aoyagi Y. Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4 cm. World J Gastroenterol. 2006;12:546-552. [PMID: 16489666 DOI: 10.3748/wjg.v12.i4.546] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
40 Shimizu K, Izumi R, Ii T, Muraoka K, Inoue T, Fukushima W, Sakamoto K, Tani T, Hashimoto T, Yagi M, Miyazaki I, Nonomura A. Prognostic significance of nucleolar organizer regions in hepatocellular carcinoma. Hepatology 1995;21:393-7. [DOI: 10.1002/hep.1840210220] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
41 Yang SH, Watanabe J, Nakashima O, Kojiro M. Clinicopathologic study on clear cell hepatocellular carcinoma. Pathol Int. 1996;46:503-509. [PMID: 8870006 DOI: 10.1111/j.1440-1827.1996.tb03645.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 2.0] [Reference Citation Analysis]
42 Romanque P, Piguet AC, Dufour JF. Targeting vessels to treat hepatocellular carcinoma. Clin Sci (Lond). 2008;114:467-477. [PMID: 18302534 DOI: 10.1042/CS20070310] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
43 Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer. 2000;88:538-543. [PMID: 10649244 DOI: 10.1002/(SICI)1097-0142(20000201)88:3%3C538::AID-CNCR7%3E3.0.CO;2-H] [Reference Citation Analysis]
44 Lau H, Fan ST, Ng IOL, Wong J. Long term prognosis after hepatectomy for hepatocellular carcinoma: A survival analysis of 204 consecutive patients. Cancer 1998;83:2302-11. [DOI: 10.1002/(sici)1097-0142(19981201)83:11<2302::aid-cncr9>3.0.co;2-1] [Cited by in Crossref: 84] [Article Influence: 3.7] [Reference Citation Analysis]
45 Chen X, Qiu F, Wu Z, Zhang Z, Huang Z, Chen Y, Zhang B, He S, Zhang W. Effects of Location and Extension of Portal Vein Tumor Thrombus on Long-Term Outcomes of Surgical Treatment for Hepatocellular Carcinoma. Ann Surg Oncol 2006;13:940-6. [DOI: 10.1245/aso.2006.08.007] [Cited by in Crossref: 86] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
46 Shouval D. HCC: what's the score. Gut 2002;50:749-50. [PMID: 12010872 DOI: 10.1136/gut.50.6.749] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
47 Oikawa T, Takayama T, Okada S, Kamo T, Sugitani M, Sakamoto M. Macroscopic portal vein tumor thrombi of liver metastasis from colorectal cancer. J Hepatobiliary Pancreat Surg 2009;16:90-3. [PMID: 19083148 DOI: 10.1007/s00534-008-0005-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
48 Roseman BJ, Roh MS. Prognostic factors in surgical resection for hepatocellular carcinoma. In: Pollock RE, editor. Surgical Oncology. Boston: Springer US; 1997. pp. 331-45. [DOI: 10.1007/978-1-4615-6165-1_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
49 Sala M, Fuster J, Llovet JM, Navasa M, Solé M, Varela M, Pons F, Rimola A, García-Valdecasas JC, Brú C. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver Transpl. 2004;10:1294-1300. [PMID: 15376311 DOI: 10.1002/lt.20202] [Cited by in Crossref: 223] [Cited by in F6Publishing: 200] [Article Influence: 13.9] [Reference Citation Analysis]
50 Vauthey J, Lauwers GY. Prognostic factors after resection of hepatocellular carcinoma: are there landmarks in the wild forest? Journal of Hepatology 2003;38:237-9. [DOI: 10.1016/s0168-8278(02)00407-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
51 Huo TI, Wu JC, Hsia CY, Chau GY, Lui WY, Huang YH, Lee PC, Chang FY, Lee SD. Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas. World J Surg 2004;28:787-91. [PMID: 15457359 DOI: 10.1007/s00268-004-7320-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
52 Kawamura Y, Ikeda K, Fujiyama S, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H. Potential of a no-touch pincer ablation procedure that uses a multipolar radiofrequency ablation system to prevent intrasubsegmental recurrence of small and single hepatocellular carcinomas. Hepatol Res 2017;47:1008-20. [PMID: 27862748 DOI: 10.1111/hepr.12838] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
53 Jepsen P, Andersen MW, Villadsen GE, Ott P, Vilstrup H. Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register-based cohort study. Liver Int 2017;37:871-8. [DOI: 10.1111/liv.13340] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
54 She WH, Chan ACY, Cheung TT, Lo CM, Chok KSH. Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels. World J Hepatol. 2018;10:308-318. [PMID: 29527266 DOI: 10.4254/wjh.v10.i2.308] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
55 Cong WM, Wu MC. Small hepatocellular carcinoma: current and future approaches. Hepatol Int. 2013;7:805-812. [PMID: 26201917 DOI: 10.1007/s12072-013-9454-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
56 Wildi S, Pestalozzi BC, McCormack L, Clavien PA. Critical evaluation of the different staging systems for hepatocellular carcinoma. Br J Surg 2004;91:400-8. [PMID: 15048738 DOI: 10.1002/bjs.4554] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
57 Cillo U, Bassanello M, Vitale A, Grigoletto FA, Burra P, Fagiuoli S, D'amico F, Ciarleglio FA, Boccagni P, Brolese A, Zanus G, D'amico DF. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? Journal of Hepatology 2004;40:124-31. [DOI: 10.1016/j.jhep.2003.09.027] [Cited by in Crossref: 133] [Cited by in F6Publishing: 119] [Article Influence: 7.8] [Reference Citation Analysis]
58 Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, Takemura S, Yamamoto T, Ikebe T, Wakasa K. Influence of previous interferon therapy on recurrence after resection of hepatitis c virus-related hepatocellular carcinoma. Jpn J Cancer Res. 2001;92:59-66. [PMID: 11173545 DOI: 10.1111/j.1349-7006.2001.tb01048.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
59 Zhou ZR, Liu M, Lu HR, Li YF, Liang SX, Zhang CY. Validation of different staging systems for hepatocellular carcinoma in a cohort of 249 patients undergoing radiotherapy. Oncotarget 2017;8:46523-31. [PMID: 28147327 DOI: 10.18632/oncotarget.14881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
60 Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States: Prognostic features, treatment outcome, and survival. Cancer 1996;77:2217-22. [DOI: 10.1002/(sici)1097-0142(19960601)77:11<2217::aid-cncr6>3.0.co;2-m] [Cited by in Crossref: 214] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
61 Nonami T, Harada A, Kurokawa T, Nakao A, Takagi H. Hepatic resection for hepatocellular carcinoma. The American Journal of Surgery 1997;173:288-91. [DOI: 10.1016/s0002-9610(96)00399-6] [Cited by in Crossref: 62] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
62 Mizuno H, Ogura M, Saito Y, Sekine W, Sano R, Gotou T, Oku T, Itoh S, Katabami K, Tsuji T. Changes in adhesive and migratory characteristics of hepatocellular carcinoma (HCC) cells induced by expression of alpha3beta1 integrin. Biochim Biophys Acta 2008;1780:564-70. [PMID: 17997226 DOI: 10.1016/j.bbagen.2007.09.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
63 Redaelli CA, Dufour JF, Wagner M, Schilling M, Hüsler J, Krähenbühl L, Büchler MW, Reichen J. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 2002;235:77-85. [PMID: 11753045 DOI: 10.1097/00000658-200201000-00010] [Cited by in Crossref: 74] [Cited by in F6Publishing: 58] [Article Influence: 3.9] [Reference Citation Analysis]
64 Nagaoki Y, Aikata H, Miyaki D, Murakami E, Hashimoto Y, Katamura Y, Azakami T, Kawaoka T, Takaki S, Hiramatsu A. Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy. J Gastroenterol. 2011;46:799-808. [PMID: 21373851 DOI: 10.1007/s00535-011-0384-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
65 Sala M, Llovet JM, Vilana R, Bianchi L, Solé M, Ayuso C, Brú C, Bruix J; for the Barcelona Cly'nic Liver Cancer (BCLC) Group. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004;40:1352-60. [DOI: 10.1002/hep.20465] [Cited by in Crossref: 330] [Cited by in F6Publishing: 278] [Article Influence: 19.4] [Reference Citation Analysis]
66 Esnaola NF, Lauwers GY, Mirza NQ, Nagorney DM, Doherty D, Ikai I, Yamaoka Y, Regimbeau JM, Belghiti J, Curley SA. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg. 2002;6:224-232; discussion 232. [PMID: 11992808 DOI: 10.1016/s1091-255x(01)00015-4] [Cited by in Crossref: 177] [Cited by in F6Publishing: 57] [Article Influence: 9.3] [Reference Citation Analysis]
67 Kumaran V. Role of liver transplantation for hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4:S97-S103. [PMID: 25755618 DOI: 10.1016/j.jceh.2014.01.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
68 Shin S, Kim TS, Lee JW, Ahn KS, Kim YH, Kang KJ. Is the anatomical resection necessary for single hepatocellular carcinoma smaller than 3 cm?: single-center experience of liver resection for a small HCC. Ann Hepatobiliary Pancreat Surg 2018;22:326-34. [PMID: 30588523 DOI: 10.14701/ahbps.2018.22.4.326] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
69 Tanaka S, Mogushi K, Yasen M, Noguchi N, Kudo A, Nakamura N, Ito K, Miki Y, Inazawa J, Tanaka H, Arii S. Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas. Surgery 2010;147:405-14. [DOI: 10.1016/j.surg.2009.09.037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
70 Herold C, Reck T, Fischler P, Ott R, Radespiel-troeger M, Ganslmayer M, Hohenberger W, Hahn EG, Schuppan D. Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre: Prognosis of hepatocellular carcinoma. Liver 2002;22:23-8. [DOI: 10.1046/j.0106-9543.2001.01571.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
71 Lim JH, Jang HJ, Kim EY, Park CK, Joh JW, Kim YI. Early recurring hepatocellular carcinoma after partial hepatic resection: preoperative CT findings. Korean J Radiol 2000;1:38-42. [PMID: 11752927 DOI: 10.3348/kjr.2000.1.1.38] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
72 Giannelli G, Bergamini C, Marinosci F, Fransvea E, Quaranta M, Lupo L, Schiraldi O, Antonaci S. Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int J Cancer 2002;97:425-31. [PMID: 11802202 DOI: 10.1002/ijc.1635] [Cited by in Crossref: 125] [Cited by in F6Publishing: 111] [Article Influence: 6.6] [Reference Citation Analysis]
73 Yoo PS, Enestvedt CK, Kulkarni S. Anatomic Considerations in the Surgical Resection of Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 2013;47:S11-5. [DOI: 10.1097/mcg.0b013e318280ce5f] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
74 Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 1998;227:424-432. [PMID: 9527066 DOI: 10.1097/00000658-199803000-00015] [Cited by in Crossref: 176] [Cited by in F6Publishing: 167] [Article Influence: 7.7] [Reference Citation Analysis]
75 Wakai T, Shirai Y, Sakata J, Kaneko K, Cruz PV, Akazawa K, Hatakeyama K. Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol. 2007;14:1356-1365. [PMID: 17252289 DOI: 10.1245/s10434-006-9318-z] [Cited by in Crossref: 130] [Cited by in F6Publishing: 114] [Article Influence: 9.3] [Reference Citation Analysis]
76 King KL, Li AF, Chau GY, Chi CW, Wu CW, Huang CL, Lui WY. Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer. 2000;88:2464-2470. [PMID: 10861421 DOI: 10.1002/1097-0142(20000601)88:11%3C2464::AID-CNCR6%3E3.0.CO;2-W] [Reference Citation Analysis]
77 Tamura S, Nakamori S, Kuroki T, Sasaki Y, Furukawa H, Ishikawa O, Imaoka S, Nakamura Y. Association of cumulative allelic losses with tumor aggressiveness in hepatocellular carcinoma. J Hepatol. 1997;27:669-676. [PMID: 9365043 DOI: 10.1016/s0168-8278(97)80084-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
78 Livraghi T, Benedini V, Lazzaroni S, Meloni F, Torzilli G, Vettori C. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 1998;83:48-57. [DOI: 10.1002/(sici)1097-0142(19980701)83:1<48::aid-cncr7>3.0.co;2-a] [Cited by in Crossref: 97] [Article Influence: 4.2] [Reference Citation Analysis]
79 Ariizumi S, Katagiri S, Katsuragawa H, Kotera Y, Yamamoto M. Sectionectomy Is Suitable for Patients with T2 Hepatocellular Carcinoma according to the Modified International Union against Cancer TNM Classification. Dig Surg 2007;24:342-8. [DOI: 10.1159/000107714] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
80 Schöniger-Hekele M, Müller C, Kutilek M, Oesterreicher C, Ferenci P, Gangl A. Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut. 2001;48:103-109. [PMID: 11115830 DOI: 10.1136/gut.48.1.103] [Cited by in Crossref: 138] [Cited by in F6Publishing: 134] [Article Influence: 6.9] [Reference Citation Analysis]
81 Huo TI, Wu JC, Lui WY, Lee PC, Huang YH, Chau GY, Tsay SH, Chang FY, Lee SD. Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection. Eur J Gastroenterol Hepatol. 2003;15:1203-1208. [PMID: 14560154 DOI: 10.1097/00042737-200311000-00009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
82 Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 2005;103:299-306. [DOI: 10.1002/cncr.20798] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 6.6] [Reference Citation Analysis]
83 Ariizumi S, Kitagawa K, Kotera Y, Takahashi Y, Katagiri S, Kuwatsuru R, Yamamoto M. A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2011;18:575-585. [PMID: 21360083 DOI: 10.1007/s00534-010-0369-y] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 7.8] [Reference Citation Analysis]
84 Hoshida Y. Difficulties in Conducting Controlled Trials in Radical Therapies for Nonadvanced Hepatocellular Carcinoma. Hepatology 2000;32:877-81. [DOI: 10.1053/jhep.2000.17918] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
85 Poon RT, Fan ST, Ng IO, Wong J. Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification. Ann Surg. 2003;237:376-383. [PMID: 12616122 DOI: 10.1097/01.sla.0000055224.68432.80] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
86 Romanzi A, Ariizumi S, Kotera Y, Omori A, Yamashita S, Katagiri S, Egawa H, Yamamoto M. Hepatocellular carcinoma with a non‐smooth tumor margin on hepatobiliary‐phase gadoxetic acid disodium‐enhanced magnetic resonance imaging. Is sectionectomy the suitable treatment? J Hepatobiliary Pancreat Sci 2020;27:922-30. [DOI: 10.1002/jhbp.743] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
87 Lee CS, Sheu JC, Wang M, Hsu HC. Long-term outcome after surgery for asymptomatic small hepatocellular carcinoma. Br J Surg 1996;83:330-3. [PMID: 8665183 DOI: 10.1002/bjs.1800830310] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 1.6] [Reference Citation Analysis]
88 Shah SA, Tan JC, McGilvray ID, Cattral MS, Levy GA, Greig PD, Grant DR. Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants. J Gastrointest Surg 2007;11:464-71. [PMID: 17436131 DOI: 10.1007/s11605-006-0033-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
89 Sumie S, Nakashima O, Okuda K, Kuromatsu R, Kawaguchi A, Nakano M, Satani M, Yamada S, Okamura S, Hori M, Kakuma T, Torimura T, Sata M. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma. Ann Surg Oncol 2014;21:1002-9. [PMID: 24254204 DOI: 10.1245/s10434-013-3376-9] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 9.5] [Reference Citation Analysis]
90 Di Costanzo GG, Signoriello S, Tortora R, Gallo C. A prognostic index for patients within the intermediate stage of hepatocellular carcinoma: . European Journal of Gastroenterology & Hepatology 2016;28:592-8. [DOI: 10.1097/meg.0000000000000562] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
91 Suarez Y, França AC, Llovet JM, Fuster J, Bruix J. THE CURRENT STATUS OF LIVER TRANSPLANTATION FOR PRIMARY HEPATIC MALIGNANCY. Clinics in Liver Disease 2000;4:591-605. [DOI: 10.1016/s1089-3261(05)70128-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Huang W, Jeng Y, Lai H, Sheu FB, Lai P, Yuan R. Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma. Langenbecks Arch Surg 2015;400:725-34. [DOI: 10.1007/s00423-015-1329-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
93 Ono T, Yamanoi A, Nazmy El Assal O, Kohno H, Nagasue N. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: Metaanalysis of three randomized controlled trials. Cancer 2001;91:2378-85. [DOI: 10.1002/1097-0142(20010615)91:12<2378::aid-cncr1271>3.0.co;2-2] [Cited by in Crossref: 76] [Article Influence: 3.8] [Reference Citation Analysis]
94 Wakai T, Shirai Y, Sakata J, Korita PV, Ajioka Y, Hatakeyama K. Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease. J Gastrointest Surg. 2011;15:1450-1458. [PMID: 21512848 DOI: 10.1007/s11605-011-1540-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
95 Giannelli G, Fransvea E, Marinosci F, Bergamini C, Colucci S, Schiraldi O, Antonaci S. Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin. Am J Pathol 2002;161:183-93. [PMID: 12107103 DOI: 10.1016/s0002-9440(10)64170-3] [Cited by in Crossref: 118] [Cited by in F6Publishing: 42] [Article Influence: 6.2] [Reference Citation Analysis]
96 Donadon M, Di Tommaso L, Soldani C, Franceschini B, Terrone A, Mimmo A, Vitali E, Roncalli M, Lania A, Torzilli G. Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy. Liver Int 2018;38:303-11. [PMID: 28727243 DOI: 10.1111/liv.13522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
97 Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Lok AS. Reply:. Hepatology 2005;42:739-40. [DOI: 10.1002/hep.20863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
98 Sanuki N, Takeda A, Kunieda E. Role of stereotactic body radiation therapy for hepatocellular carcinoma. World J Gastroenterol. 2014;20:3100-3111. [PMID: 24696597 DOI: 10.3748/wjg.v20.i12.3100] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 37] [Article Influence: 7.7] [Reference Citation Analysis]
99 Kitamura K, Hatano E, Higashi T, Narita M, Seo S, Nakamoto Y, Yamanaka K, Nagata H, Taura K, Yasuchika K. Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis. J Hepatol. 2011;55:846-857. [PMID: 21334407 DOI: 10.1016/j.jhep.2011.01.038] [Cited by in Crossref: 86] [Cited by in F6Publishing: 81] [Article Influence: 8.6] [Reference Citation Analysis]
100 Pang RWC, Joh JW, Johnson PJ, Monden M, Pawlik TM, Poon RTP. Biology of Hepatocellular Carcinoma. Ann Surg Oncol 2008;15:962-71. [DOI: 10.1245/s10434-007-9730-z] [Cited by in Crossref: 122] [Cited by in F6Publishing: 110] [Article Influence: 9.4] [Reference Citation Analysis]
101 Andant C, Puy H, Bogard C, Faivre J, Soulé JC, Nordmann Y, Deybach JC. Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. J Hepatol. 2000;32:933-939. [PMID: 10898313 DOI: 10.1016/s0168-8278(00)80097-5] [Cited by in Crossref: 85] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
102 Iwadou S, Nouso K, Kuwaki K, Kobayashi Y, Nakamura S, Tanaka H, Miyoshi K, Ohnishi H, Miyake Y, Shiraha H, Iwasaki Y, Shiratori Y, Yamamoto K. Time-dependent analysis of predisposing factors for the recurrence of hepatocellular carcinoma: Factors for HCC recurrence. Liver International 2010;30:1027-32. [DOI: 10.1111/j.1478-3231.2010.02252.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
103 Daniele B, De Sio I, Izzo F, Capuano G, Andreana A, Mazzanti R, Aiello A, Vallone P, Fiore F, Gaeta GB. Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a Cancer of the Liver Italian Program (CLIP 08) retrospective case-control study. J Clin Gastroenterol. 2003;36:63-67. [PMID: 12488711 DOI: 10.1097/00004836-200301000-00017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
104 Jeon SW, Lee MK, Lee YD, Seo HE, Cho CM, Tak WY, Kweon YO. Clear cell hepatocellular carcinoma with spontaneous regression of primary and metastatic lesions. Korean J Intern Med. 2005;20:268-273. [PMID: 16295790 DOI: 10.3904/kjim.2005.20.3.268] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
105 Chau GY, Wu CW, Lui WY, Chang TJ, Kao HL, Wu LH, King KL, Loong CC, Hsia CY, Chi CW. Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg. 2000;231:552-558. [PMID: 10749617 DOI: 10.1097/00000658-200004000-00015] [Cited by in Crossref: 94] [Cited by in F6Publishing: 89] [Article Influence: 4.5] [Reference Citation Analysis]
106 Park CH, Jeong SH, Yim HW, Kim JD, Bae SH, Choi JY, Yoon SK. Family history influences the early onset of hepatocellular carcinoma. World J Gastroenterol. 2012;18:2661-2667. [PMID: 22690075 DOI: 10.3748/wjg.v18.i21.2661] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
107 el-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Yu L, Nagasue N. Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma. Surgery. 1997;122:571-577. [PMID: 9308615 DOI: 10.1016/s0039-6060(97)90130-6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
108 Pan HW, Ou YH, Peng SY, Liu SH, Lai PL, Lee PH, Sheu JC, Chen CL, Hsu HC. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer. 2003;98:119-127. [PMID: 12833464 DOI: 10.1002/cncr.11487] [Cited by in Crossref: 169] [Cited by in F6Publishing: 153] [Article Influence: 9.4] [Reference Citation Analysis]
109 Sugiura T, Nagino M, Ebata T, Arai T, Oda K, Yuasa N, Nimura Y. Treatment of colorectal liver metastasis with biliary and portal vein tumor thrombi by hepatopancreatoduodenectomy. J Hepatobiliary Pancreat Surg 2006;13:256-9. [DOI: 10.1007/s00534-005-1043-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
110 Staudacher C, Chiappa A, Biella F, Audisio RA, Bertani E, Zbar AP. Validation of the Modified Tnm-Izumi Classification for Hepatocellular Carcinoma. Tumori 2000;86:8-11. [DOI: 10.1177/030089160008600102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
111 Uraki J, Yamakado K, Nakatsuka A, Takeda K. Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors. Eur J Radiol. 2004;51:12-18. [PMID: 15186879 DOI: 10.1016/s0720-048x(03)00219-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
112 Wan P, Xia Q, Zhang JJ, Li QG, Xu N, Zhang M, Chen XS, Han LZ. Liver transplantation for hepatocellular carcinoma exceeding the Milan criteria: a single-center experience. J Cancer Res Clin Oncol 2014;140:341-8. [PMID: 24374832 DOI: 10.1007/s00432-013-1576-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
113 Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A. Simplified staging for hepatocellular carcinoma. J Clin Oncol. 2002;20:1527-1536. [PMID: 11896101 DOI: 10.1200/jco.2002.20.6.1527] [Cited by in Crossref: 240] [Cited by in F6Publishing: 181] [Article Influence: 12.6] [Reference Citation Analysis]
114 Ito T, Kumada T, Toyoda H, Tada T. FIB-4 index for assessing the prognosis of hepatocellular carcinoma in patients with Child-Pugh class A liver function. J Cancer Res Clin Oncol. 2015;141:1311-1319. [PMID: 25648362 DOI: 10.1007/s00432-015-1922-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
115 Pinna AD, Iwatsuki S, Lee RG, Todo S, Madariaga JR, Marsh JW, Casavilla A, Dvorchik I, Fung JJ, Starzl TE. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology. 1997;26:877-883. [PMID: 9328308 DOI: 10.1002/hep.510260412] [Cited by in Crossref: 116] [Cited by in F6Publishing: 88] [Article Influence: 4.8] [Reference Citation Analysis]
116 Tsai S, Nathan H, Pawlik TM. Primary liver cancer: intrahepatic cholangiocarcinoma emerges from the shadows. Updates Surg 2010;62:5-9. [DOI: 10.1007/s13304-010-0011-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
117 Yang P, Wu D, Xia Y, Li J, Wang K, Yan Z, Shi L, Lau WY, Wu M, Shen F. A prognostic scoring system for patients with multiple hepatocellular carcinomas treated by hepatectomy. Ann Surg Oncol 2015;22:826-33. [PMID: 25216602 DOI: 10.1245/s10434-014-4081-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
118 Zhang Y, Wu YF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Wang T, Liu FQ. Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus. World J Gastrointest Oncol 2019;11:310-21. [PMID: 31040896 DOI: 10.4251/wjgo.v11.i4.310] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
119 Kubo S, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, Yamamoto T, Ikebe T, Wakasa K, Nishiguchi S, Kinoshita H. Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma. Cancer 2000;88:1016-24. [DOI: 10.1002/(sici)1097-0142(20000301)88:5<1016::aid-cncr10>3.0.co;2-v] [Cited by in Crossref: 75] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
120 Greally M, Pilson K, Linehan A, O'Keane C, Shields CJ, Conneely JB, McCaffrey JA. Indolent Nodal Relapse of Colon Carcinoma with Associated Tumor Thrombus Invading the Superior Mesenteric Vein. J Gastrointest Cancer 2019;50:660-4. [PMID: 29663116 DOI: 10.1007/s12029-018-0101-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Imura S, Teraoku H, Yoshikawa M, Ishikawa D, Yamada S, Saito Y, Iwahashi S, Ikemoto T, Morine Y, Shimada M. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria. Int J Clin Oncol 2018;23:98-103. [PMID: 28875240 DOI: 10.1007/s10147-017-1189-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
122 Egawa M, Yoshida Y, Ogura S, Kurahashi T, Kizu T, Furuta K, Kamada Y, Chatani N, Hamano M, Kiso S, Hikita H, Tatsumi T, Eguchi H, Nagano H, Doki Y, Mori M, Takehara T. Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma: FoxM1 as a universal prognostic biomarker for HCC. Hepatol Res 2017;47:1196-205. [DOI: 10.1111/hepr.12854] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
123 Lei HJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Wu CW. Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J Am Coll Surg. 2006;203:426-435. [PMID: 17000385 DOI: 10.1016/j.jamcollsurg.2006.06.030] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 4.5] [Reference Citation Analysis]
124 Wakai T, Shirai Y, Nomura T, Nagakura S, Hatakeyama K. Computed tomographic features of hepatocellular carcinoma predict long-term survival after hepatic resection. European Journal of Surgical Oncology (EJSO) 2002;28:235-42. [DOI: 10.1053/ejso.2001.1241] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
125 Daniele B, Perrone F. Staging for Liver Cancer. Clinics in Liver Disease 2005;9:213-23. [DOI: 10.1016/j.cld.2004.12.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
126 Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. Journal of Hepatology 2003;38:136-49. [DOI: 10.1016/s0168-8278(02)00432-4] [Cited by in Crossref: 156] [Cited by in F6Publishing: 54] [Article Influence: 8.7] [Reference Citation Analysis]
127 Spolverato G, Yakoob MY, Kim Y, Alexandrescu S, Marques HP, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Marsh JW, Pawlik TM. The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2015;22:4020-4028. [PMID: 25762481 DOI: 10.1245/s10434-015-4472-9] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 10.5] [Reference Citation Analysis]
128 Pawlik TM. Debate: Resection for early hepatocellular carcinoma. J Gastrointest Surg 2009;13:1026-8. [PMID: 19104903 DOI: 10.1007/s11605-008-0779-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
129 Poon RT, Ng IO, Fan S, Lai EC, Lo C, Liu C, Wong J. Clinicopathologic Features of Long-Term Survivors and Disease-Free Survivors After Resection of Hepatocellular Carcinoma: A Study of a Prospective Cohort. JCO 2001;19:3037-44. [DOI: 10.1200/jco.2001.19.12.3037] [Cited by in Crossref: 113] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
130 Vauthey JN, Klimstra D, Blumgart LH. A simplified staging system for hepatocellular carcinomas. Gastroenterology 1995;108:617-8. [PMID: 7835611 DOI: 10.1016/0016-5085(95)90109-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
131 Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 2007;72 Suppl 1:98-103. [PMID: 18087189 DOI: 10.1159/000111714] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 5.1] [Reference Citation Analysis]
132 Iizuka N, Oka M, Yamada-Okabe H, Nishida M, Maeda Y, Mori N, Takao T, Tamesa T, Tangoku A, Tabuchi H. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet. 2003;361:923-929. [PMID: 12648972 DOI: 10.1016/s0140-6736(03)12775-4] [Cited by in Crossref: 356] [Cited by in F6Publishing: 109] [Article Influence: 19.8] [Reference Citation Analysis]
133 American Joint Committee on Cancer. Liver (Including Intrahepatic Bile Ducts). In: Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, editors. AJCC Cancer Staging Manual. New York: Springer; 2002. pp. 131-8. [DOI: 10.1007/978-1-4757-3656-4_14] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
134 Cho YK, Chung JW, Kim JK, Ahn YS, Kim MY, Park YO, Kim WT, Byun JH. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer. 2008;112:352-361. [PMID: 18008352 DOI: 10.1002/cncr.23185] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 6.4] [Reference Citation Analysis]
135 Huo T, Wu J, Lui W, Huang Y, Lee P, Chiang J, Chang F, Lee S. Differential Mechanism and Prognostic Impact of Diabetes Mellitus on Patients with Hepatocellular Carcinoma Undergoing Surgical and Nonsurgical Treatment. Am J Gastroenterology 2004;99:1479-87. [DOI: 10.1111/j.1572-0241.2004.30024.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
136 Kee KM, Wang JH, Lee CM, Chen CL, Changchien CS, Hu TH, Cheng YF, Hsu HC, Wang CC, Chen TY, Lin CY, Lu SN. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer. 2007;120:2650-2655. [PMID: 17304512 DOI: 10.1002/ijc.22616] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 5.3] [Reference Citation Analysis]
137 Song SS, Ying JF, Zhang YN, Pan HY, He XL, Hu ZM, Wang HJ, Dou XB, Mou XZ. High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma. Oncol Lett 2020;19:3181-8. [PMID: 32256814 DOI: 10.3892/ol.2020.11430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
138 Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10-24. [PMID: 10862190 DOI: 10.1097/00000658-200007000-00003] [Cited by in Crossref: 551] [Cited by in F6Publishing: 522] [Article Influence: 26.2] [Reference Citation Analysis]
139 Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K, Maeda T, Shirabe K, Yanaga K, Sugimachi K. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998;227:80-5. [PMID: 9445114 DOI: 10.1097/00000658-199801000-00012] [Cited by in Crossref: 120] [Cited by in F6Publishing: 111] [Article Influence: 5.2] [Reference Citation Analysis]
140 Johnson P, Bruix J. Hepatocellular carcinoma and the art of prognostication. Journal of Hepatology 2000;33:1006-8. [DOI: 10.1016/s0168-8278(00)80137-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
141 Tung W, Chau G, Loong C, Wu J, Tsay S, King K, Huang S, Chiu J, Wu C, Lui W. Surgical resection of primary hepatocellular carcinoma extending to adjacent organ(s). European Journal of Surgical Oncology (EJSO) 1996;22:516-20. [DOI: 10.1016/s0748-7983(96)93056-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
142 Dodson RM, He J, Pawlik TM. Resection and transplantation for hepatocellular carcinoma: factors influencing surgical options. Future Oncology 2014;10:587-607. [DOI: 10.2217/fon.13.225] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
143 Van Deusen MA, Abdalla EK, Vauthey JN, Roh MS. Staging classifications for hepatocellular carcinoma. Expert Rev Mol Diagn 2005;5:377-83. [PMID: 15934814 DOI: 10.1586/14737159.5.3.377] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
144 Seong J, Lee IJ, Shim SJ, Lim DH, Kim TH, Kim JH, Jang HS, Kim MS, Chie EK, Kim JH, Nam TK, Lee HS, Han CJ. A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea. Liver Int 2009;29:147-52. [PMID: 18795897 DOI: 10.1111/j.1478-3231.2008.01873.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 3.7] [Reference Citation Analysis]
145 Adachi E, Maehara S, Tsujita E, Taguchi K, Aishima S, Rikimaru T, Yamashita Y, Tanaka S. Clinicopathologic risk factors for recurrence after a curative hepatic resection for hepatocellular carcinoma. Surgery. 2002;131:S148-S152. [PMID: 11821802 DOI: 10.1067/msy.2002.119496] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
146 Donckier V, Van Laethem JL, Van Gansbeke D, Ickx B, Lingier P, Closset J, El Nakadi I, Feron P, Boon N, Bourgeois N, Adler M, Gelin M. New considerations for an overall approach to treat hepatocellular carcinoma in cirrhotic patients. J Surg Oncol 2003;84:36-44. [DOI: 10.1002/jso.10281] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
147 Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati PL, Pigato P. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer 1998;82:1028-36. [PMID: 9506346 DOI: 10.1002/(sici)1097-0142(19980315)82:6<1028::aid-cncr4>3.0.co;2-a] [Cited by in Crossref: 110] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
148 Pons F, Varela M, Llovet JM. Staging systems in hepatocellular carcinoma. HPB (Oxford). 2005;7:35-41. [PMID: 18333159 DOI: 10.1080/13651820410024058] [Cited by in Crossref: 153] [Cited by in F6Publishing: 134] [Article Influence: 13.9] [Reference Citation Analysis]
149 Tada T, Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kitabatake S, Kuzuya T, Nonogaki K. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma. Liver Int. 2005;25:848-853. [PMID: 15998436 DOI: 10.1111/j.1478-3231.2005.01111.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 3.0] [Reference Citation Analysis]
150 Imamura H, Matsuyama Y, Miyagawa Y, Ishida K, Shimada R, Miyagawa S, Makuuchi M, Kawasaki S. Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg. 1999;86:1032-1038. [PMID: 10460639 DOI: 10.1046/j.1365-2168.1999.01185.x] [Cited by in Crossref: 160] [Cited by in F6Publishing: 155] [Article Influence: 7.3] [Reference Citation Analysis]
151 Chen TW, Chu CM, Yu JC, Chen CJ, Chan DC, Liu YC, Hsieh CB. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy. Eur J Surg Oncol. 2007;33:480-487. [PMID: 17129701 DOI: 10.1016/j.ejso.2006.10.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
152 Sharma R, Gibbs JF. Recent advances in the management of primary hepatic tumors refinement of surgical techniques and effect on outcome. J Surg Oncol 2010;101:745-54. [DOI: 10.1002/jso.21506] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
153 Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008;15:1375-1382. [PMID: 18324443 DOI: 10.1245/s10434-008-9846-9] [Cited by in Crossref: 249] [Cited by in F6Publishing: 233] [Article Influence: 19.2] [Reference Citation Analysis]
154 Peng ZW, Guo RP, Zhang YJ, Lin XJ, Chen MS, Lau WY. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Cancer. 2012;118:4725-4736. [PMID: 22359112 DOI: 10.1002/cncr.26561] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 10.8] [Reference Citation Analysis]
155 Jiang X, Yu X, Huang R, Zhu H, Chen X, Xiong J, Chen Z, Huang X, Shen X, Zhu J. Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma. J Cancer Res Clin Oncol 2016;142:2309-17. [DOI: 10.1007/s00432-016-2232-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
156 Pirisi M, Toniutto P, Uzzau A, Fabris C, Avellini C, Scott C, Apollonio L, Beltrami CA, Bresadola F. Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients. Cancer 2000;89:297-302. [PMID: 10918159 DOI: 10.1002/1097-0142(20000715)89:2<297::aid-cncr14>3.0.co;2-n] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
157 Chen XP, Huang ZY. Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes. Langenbecks Arch Surg. 2005;390:259-265. [PMID: 15875211 DOI: 10.1007/s00423-005-0552-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
158 Mela M, Mancuso A, Burroughs AK. Review article: hepatocellular carcinoma: indications for liver transplantation. Aliment Pharmacol Ther. 2003;17 Suppl 2:130-137. [PMID: 12786624 DOI: 10.1046/j.1365-2036.17.s2.16.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
159 Esaki M, Shimada K, Sano T, Sakamoto Y, Kosuge T, Ojima H. Surgical results for hepatocellular carcinoma with bile duct invasion: a clinicopathologic comparison between macroscopic and microscopic tumor thrombus. J Surg Oncol 2005;90:226-32. [PMID: 15906365 DOI: 10.1002/jso.20260] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
160 Nonami T, Harada A, Kurokawa T, Nakao A, Takagi H. Advances in hepatic resection and results for hepatocellular carcinoma. Semin Surg Oncol 1996;12:183-8. [DOI: 10.1002/(sici)1098-2388(199605/06)12:3<183::aid-ssu7>3.0.co;2-3] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
161 Shi M, Guo RP, Lin XJ, Zhang YQ, Chen MS, Zhang CQ, Lau WY, Li JQ. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg. 2007;245:36-43. [PMID: 17197963 DOI: 10.1097/01.sla.0000231758.07868.71] [Cited by in Crossref: 290] [Cited by in F6Publishing: 263] [Article Influence: 20.7] [Reference Citation Analysis]
162 Miyaaki H, Nakashima O, Kurogi M, Eguchi K, Kojiro M. Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma. J Gastroenterol. 2007;42:962-968. [PMID: 18085353 DOI: 10.1007/s00535-007-2117-x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 5.1] [Reference Citation Analysis]
163 Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg. 2005;242:252-259. [PMID: 16041216 DOI: 10.1097/01.sla.0000171307.37401.db.] [Reference Citation Analysis]
164 Bruix J, Llovet JM. Locoregional treatments for hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol. 1999;13:611-622. [PMID: 10654923 DOI: 10.1053/bega.1999.0051] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
165 Tannus RK, Almeida-Carvalho SR, Loureiro-Matos CA, Miziara-Gonzalez A, Salzedas-Netto AA, Szejnfeld D, D'Ippolito G, Pereira-Lanzoni V, Souza-Silva I. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems. PLoS One 2018;13:e0194922. [PMID: 29617435 DOI: 10.1371/journal.pone.0194922] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
166 Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, Ohgi K, Aramaki T, Uesaka K. Anatomical resection is useful for the treatment of primary solitary hepatocellular carcinoma with predicted microscopic vessel invasion and/or intrahepatic metastasis. Surg Today 2021;51:1429-39. [PMID: 33564928 DOI: 10.1007/s00595-021-02237-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Fuster J, García-Valdecasas JC, Grande L, Tabet J, Bruix J, Anglada T, Taurá P, Lacy AM, González X, Vilana R. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg. 1996;223:297-302. [PMID: 8604911 DOI: 10.1097/00000658-199603000-00011] [Cited by in Crossref: 168] [Cited by in F6Publishing: 163] [Article Influence: 6.7] [Reference Citation Analysis]
168 Lee HA, Lee YS, Kim BK, Jung YK, Kim SU, Park JY, Kim JH, An H, Kim DY, Yim HJ, Ahn SH, Yeon JE, Byun KS, Han KH, Um SH, Seo YS. Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma. Gut Liver 2021;15:420-9. [PMID: 32839362 DOI: 10.5009/gnl20101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 King KL, Li AF, Chau GY, Chi CW, Wu CW, Huang CL, Lui WY. Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer 2000;88:2464-70. [PMID: 10861421 DOI: 10.1002/1097-0142(20000601)88:11<2464::aid-cncr6>3.0.co;2-w] [Cited by in Crossref: 52] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
170 Minagawa M, Makuuchi M, Takayama T, Ohtomo K. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg. 2001;233:379-384. [PMID: 11224626 DOI: 10.1097/00000658-200103000-00012] [Cited by in Crossref: 149] [Cited by in F6Publishing: 127] [Article Influence: 7.5] [Reference Citation Analysis]
171 Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg. 2005;242:252-259. [PMID: 16041216 DOI: 10.1097/01.sla.0000171307.37401.db] [Cited by in Crossref: 452] [Cited by in F6Publishing: 383] [Article Influence: 28.3] [Reference Citation Analysis]
172 Chapel F, Guettier C, Chastang C, Rached AA, Mathieu D, Tepper M, Beaugrand M, Trinchet J; Group d'Etude et de Traitement du Carcinoma Hépatocellulaire. Needle biopsy of hepatocellular carcinoma: Assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Cancer 1996;77:864-71. [DOI: 10.1002/(sici)1097-0142(19960301)77:5<864::aid-cncr9>3.0.co;2-e] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
173 Lee HA, Park S, Seo YS, Yoon WS, Shin I, Rim CH. Surgery versus external beam radiotherapy for hepatocellular carcinoma involving the inferior vena cava or right atrium: A systematic review and meta‐analysis. J Hepatobiliary Pancreat Sci. [DOI: 10.1002/jhbp.865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
174 Seong J, Shim SJ, Lee IJ, Han KH, Chon CY, Ahn SH. Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1037-42. [PMID: 17234356 DOI: 10.1016/j.ijrobp.2006.10.035] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
175 Shi M, Guo RP, Lin XJ, Zhang YQ, Chen MS, Zhang CQ, Lau WY, Li JQ. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg. 2007;245:36-43. [PMID: 17197963 DOI: 10.1097/01.sla.0000231758.07868.71.] [Reference Citation Analysis]
176 Kawamura Y, Ikeda K, Hirakawa M, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F. New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma. Hepatol Res. 2010;40:1006-1014. [PMID: 20887336 DOI: 10.1111/j.1872-034x.2010.00703.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
177 Zhang H, Yuan SX, Dai SY, Zhang JM, Huang X, Lu CD, Lu JH, Wu FQ, Lau WY, Wu MC, Yang T, Shen F. Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion. World J Surg 2014;38:947-57. [PMID: 24258262 DOI: 10.1007/s00268-013-2365-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
178 Sakata J, Shirai Y, Wakai T, Kaneko K, Nagahashi M, Hatakeyama K. Preoperative predictors of vascular invasion in hepatocellular carcinoma. Eur J Surg Oncol. 2008;34:900-905. [PMID: 18343084 DOI: 10.1016/j.ejso.2008.01.031] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
179 Huo T, Huang Y, Wu J, Lee P, Chang F, Lee S. Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study. Annals of Oncology 2004;15:775-80. [DOI: 10.1093/annonc/mdh184] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
180 Erstad DJ, Tanabe KK. Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma. Ann Surg Oncol 2019;26:1474-93. [DOI: 10.1245/s10434-019-07227-9] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 22.0] [Reference Citation Analysis]
181 Kurokawa Y, Matoba R, Takemasa I, Nagano H, Dono K, Nakamori S, Umeshita K, Sakon M, Ueno N, Oba S. Molecular-based prediction of early recurrence in hepatocellular carcinoma. J Hepatol. 2004;41:284-291. [PMID: 15288478 DOI: 10.1016/j.jhep.2004.04.031] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 5.2] [Reference Citation Analysis]
182 Lee HA, Goh HG, Lee YS, Jung YK, Kim JH, Yim HJ, Lee MG, An H, Jeen YT, Yeon JE, Byun KS, Seo YS. Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma. BMC Gastroenterol 2021;21:258. [PMID: 34118869 DOI: 10.1186/s12876-021-01833-2] [Reference Citation Analysis]
183 Kee KM, Wang JH, Lin CY, Wang CC, Cheng YF, Lu SN. Validation of the 7th edition TNM staging system for hepatocellular carcinoma: an analysis of 8,828 patients in a single medical center. Dig Dis Sci. 2013;58:2721-2728. [PMID: 23703450 DOI: 10.1007/s10620-013-2716-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
184 Otani K, Ishihara S, Hata K, Murono K, Sasaki K, Yasuda K, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K. Colorectal cancer with venous tumor thrombosis. Asian J Surg. 2016; Epub ahead of print. [PMID: 27693064 DOI: 10.1016/j.asjsur.2016.07.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
185 Tamura Y, Igarashi M, Suda T, Wakai T, Shirai Y, Umemura T, Tanaka E, Kakizaki S, Takagi H, Hiasa Y, Onji M, Aoyagi Y. Fucosylated Fraction of Alpha-Fetoprotein as a Predictor of Prognosis in Patients with Hepatocellular Carcinoma After Curative Treatment. Dig Dis Sci 2010;55:2095-101. [DOI: 10.1007/s10620-009-0954-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
186 Duffy JP, Hiatt JR, Busuttil RW. Surgical resection of hepatocellular carcinoma. Cancer J. 2008;14:100-110. [PMID: 18391615 DOI: 10.1097/ppo.0b013e31816a5c1f] [Cited by in Crossref: 39] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
187 Khan KN, Yatsuhashi H, Yamasaki K, Yamasaki M, Inoue O, Koga M, Yano M. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol. 2000;32:269-278. [PMID: 10707867 DOI: 10.1016/s0168-8278(00)80072-0] [Cited by in Crossref: 106] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
188 Sakamoto K, Nagano H. Surgical treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus. Hepatol Res. 2017;47:957-962. [PMID: 28618075 DOI: 10.1111/hepr.12923] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
189 Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, Yoshida H, Shiina S, Omata M. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 2001;91:561-9. [PMID: 11169939 DOI: 10.1002/1097-0142(20010201)91:3<561::aid-cncr1035>3.0.co;2-n] [Cited by in Crossref: 210] [Cited by in F6Publishing: 69] [Article Influence: 10.5] [Reference Citation Analysis]
190 Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ, Starzl TE. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000;191:389-394. [PMID: 11030244 DOI: 10.1016/s1072-7515(00)00688-8] [Cited by in Crossref: 164] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
191 Yasuda E, Kumada T, Takai S, Ishisaki A, Noda T, Matsushima-Nishiwaki R, Yoshimi N, Kato K, Toyoda H, Kaneoka Y. Attenuated phosphorylation of heat shock protein 27 correlates with tumor progression in patients with hepatocellular carcinoma. Biochem Biophys Res Commun. 2005;337:337-342. [PMID: 16199221 DOI: 10.1016/j.bbrc.2005.08.273] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
192 Okamura Y, Ito T, Sugiura T, Mori K, Uesaka K. Anatomic versus nonanatomic hepatectomy for a solitary hepatocellular carcinoma : a case-controlled study with propensity score matching. J Gastrointest Surg 2014;18:1994-2002. [PMID: 25213582 DOI: 10.1007/s11605-014-2646-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 7.7] [Reference Citation Analysis]
193 Huo TI, Lui WY, Huang YH, Chau GY, Wu JC, Lee PC, Chang FY, Lee SD. Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol. 2003;98:2293-2298. [PMID: 14572582 DOI: 10.1111/j.1572-0241.2003.07688.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
194 Poon RT, Fan ST. Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin N Am. 2003;12:35-50, viii. [PMID: 12735128 DOI: 10.1016/s1055-3207(02)00086-8] [Cited by in Crossref: 74] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
195 Utsunomiya T, Ogawa K, Yoshinaga K, Ohta M, Yamashita K, Mimori K, Inoue H, Ezaki T, Yoshikawa Y, Mori M. Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinoma. Int J Cancer. 2005;116:105-109. [PMID: 15756681 DOI: 10.1002/ijc.20986] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
196 Ryu T, Takami Y, Wada Y, Tateishi M, Hara T, Yoshitomi M, Momosaki S, Yasumori K, Saitsu H, Okuda K. A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria. J Gastrointest Surg 2019;23:779-87. [PMID: 30788712 DOI: 10.1007/s11605-019-04134-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
197 Wahab MA, Shehta A, Hamed H, El Nakeeb A, Salah T. Predictors of recurrence in hepatitis C virus related hepatocellular carcinoma after hepatic resection: a retrospective cohort study. Eurasian J Med 2014;46:36-41. [PMID: 25610292 DOI: 10.5152/eajm.2014.07] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
198 Daniele B, Annunziata M, Barletta E, Tinessa V, Di Maio M. Cancer of the Liver Italian Program (CLIP) score for staging hepatocellular carcinoma. Hepatology Research 2007;37:S206-9. [DOI: 10.1111/j.1872-034x.2007.00186.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
199 Kubo S, Nishiguchi S, Shuto T, Tanaka H, Tsukamoto T, Hirohashi K, Ikebe T, Wakasa K, Kuroki T, Kinoshita H. Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma. Jpn J Cancer Res 1999;90:162-70. [PMID: 10189886 DOI: 10.1111/j.1349-7006.1999.tb00729.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
200 Huo T, Wu J, Lui W, Lee R, Loong C, Huang Y, Tsay S, Chang F, Lee S. Reliability of contemporary radiology to measure tumour size of hepatocellular carcinoma in patients undergoing resection: limitations and clinical implications. Scandinavian Journal of Gastroenterology 2009;39:46-52. [DOI: 10.1080/00365520310007242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
201 Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg. 2007;245:909-922. [PMID: 17522517 DOI: 10.1097/01.sla.0000254368.65878.da] [Cited by in Crossref: 220] [Cited by in F6Publishing: 207] [Article Influence: 15.7] [Reference Citation Analysis]
202 Kamiyama T, Yokoo H, Kakisaka T, Orimo T, Wakayama K, Kamachi H, Tsuruga Y, Yamashita K, Shimamura T, Todo S, Taketomi A. Multiplication of alpha-fetoprotein and protein induced by vitamin K absence-II is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomy. Hepatol Res 2015;45:E21-31. [PMID: 25382703 DOI: 10.1111/hepr.12451] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
203 Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology. 1998;27:407-414. [PMID: 9462638 DOI: 10.1002/hep.510270214] [Cited by in Crossref: 253] [Cited by in F6Publishing: 221] [Article Influence: 11.0] [Reference Citation Analysis]
204 Kishi Y, Hasegawa K, Kokudo N. Surgical resection for small hepatocellular carcinoma in cirrhosis: the Eastern experience. Recent Results Cancer Res 2013;190:69-84. [PMID: 22941014 DOI: 10.1007/978-3-642-16037-0_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
205 Faber W, Stockmann M, Schirmer C, Möllerarnd A, Denecke T, Bahra M, Klein F, Schott E, Neuhaus P, Seehofer D. Significant impact of patient age on outcome after liver resection for HCC in cirrhosis. Eur J Surg Oncol. 2014;40:208-213. [PMID: 24275202 DOI: 10.1016/j.ejso.2013.10.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
206 Dohmen K. Many staging systems for hepatocellular carcinoma: Evolution from Child-Pugh, Okuda to SLiDe. J Gastroenterol Hepatol 2004;19:1227-32. [DOI: 10.1111/j.1440-1746.2004.03538.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
207 Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology. 2002;122:1609-1619. [PMID: 12016426 DOI: 10.1053/gast.2002.33411] [Cited by in Crossref: 374] [Cited by in F6Publishing: 349] [Article Influence: 19.7] [Reference Citation Analysis]
208 Huo TI, Huang YH, Wu JC, Chiang JH, Lee PC, Chang FY, Lee SD. Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. Ann Oncol 2003;14:1648-53. [PMID: 14581273 DOI: 10.1093/annonc/mdg460] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
209 Tateishi R, Yoshida H, Shiina S, Imamura H, Hasegawa K, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Makuuchi M, Omata M. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut. 2005;54:419-425. [PMID: 15710994 DOI: 10.1136/gut.2003.035055] [Cited by in Crossref: 174] [Cited by in F6Publishing: 155] [Article Influence: 10.9] [Reference Citation Analysis]
210 Mino M, Lauwers GY. Pathologic spectrum and prognostic significance of underlying liver disease in hepatocellular carcinoma. Surg Oncol Clin N Am. 2003;12:13-24. [PMID: 12735126 DOI: 10.1016/s1055-3207(02)00087-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
211 Kaibori M, Ishizaki M, Matsui K, Kwon AH. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. J Surg Oncol. 2010;102:462-468. [PMID: 20872949 DOI: 10.1002/jso.21631] [Cited by in Crossref: 91] [Cited by in F6Publishing: 84] [Article Influence: 8.3] [Reference Citation Analysis]
212 Savci G. The changing role of radiology in imaging liver tumors: an overview. Eur J Radiol. 1999;32:36-51. [PMID: 10580321 DOI: 10.1016/s0720-048x(99)00113-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
213 Nanashima A, Sumida Y, Morino S, Yamaguchi H, Tanaka K, Shibasaki S, Ide N, Sawai T, Yasutake T, Nakagoe T. The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy. Eur J Surg Oncol. 2004;30:765-770. [PMID: 15296991 DOI: 10.1016/j.ejso.2004.05.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
214 Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434-1440. [PMID: 10573522 DOI: 10.1002/hep.510300629] [Cited by in Crossref: 1259] [Cited by in F6Publishing: 1099] [Article Influence: 57.2] [Reference Citation Analysis]
215 Sakamoto K, Ogawa K, Tohyama T, Ueno Y, Tamura K, Inoue H, Nakamura T, Watanabe J, Takai A, Takada Y. Serosal invasion is a strong prognostic factor for hepatocellular carcinoma after hepatectomy. Hepatol Res 2019;49:419-31. [PMID: 30403431 DOI: 10.1111/hepr.13285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
216 Kawamura Y, Ikeda K, Fukushima T, Hara T, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H. Potential of a no-touch pincer ablation procedure for small hepatocellular carcinoma that uses a multipolar radiofrequency ablation system: An experimental animal study: No-touch ablation procedure for hepatic tumors. Hepatol Res 2014;44:1234-40. [DOI: 10.1111/hepr.12240] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
217 Huang Y, Chen C, Chang T, Chen S, Wang S, Lee H, Lin P, Huang G, Sheu J, Tsai H, Lee P, Chau G, Lui W, Lee S, Wu J. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. J Gastroenterol Hepatol 2005;20:765-71. [DOI: 10.1111/j.1440-1746.2005.03746.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
218 Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg. 2005;242:252-259. [PMID: 16041216 DOI: 10.1097/01.sla.0000171307.37401] [Reference Citation Analysis]
219 Zheng T, Xie F, Geng L, Sui CJ, Dai DH, Shen RX, Yan L, Yang JM. Safety and long-term outcomes of anatomic left hepatic trisectionectomy for intermediate and advanced hepatocellular carcinoma. J Gastroenterol Hepatol 2015;30:1015-23. [PMID: 25641605 DOI: 10.1111/jgh.12887] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
220 Cruz PV, Wakai T, Shirai Y, Yokoyama N, Hatakeyama K. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression is an adverse prognostic factor in hepatocellular carcinoma. Cancer 2005;104:354-60. [DOI: 10.1002/cncr.21159] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
221 Varela M, Sala M, Llovet JM, Bruix J. Natural history and prognostic prediction of patients with hepatocellular carcinoma: REVIEW: NATURAL HISTORY AND PROGNOSTIC PREDICTION. Alimentary Pharmacology & Therapeutics 2003;17:98-102. [DOI: 10.1046/j.1365-2036.17.s2.11.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
222 Nanashima A, Morino S, Yamaguchi H, Tanaka K, Shibasaki S, Tsuji T, Hidaka S, Sawai T, Yasutake T, Nakagoe T. Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO) 2003;29:735-42. [DOI: 10.1016/j.ejso.2003.08.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
223 Keshavarzian A, Fields JZ. A radical perspective on ulcerative colitis. J Gastroenterol Hepatol 1995;10:208-9. [DOI: 10.1111/j.1440-1746.1995.tb01080.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
224 Chen JS, Wang Q, Chen XL, Huang XH, Liang LJ, Lei J, Huang JQ, Li DM, Cheng ZX. Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis. J Surg Res. 2012;175:243-250. [PMID: 21601221 DOI: 10.1016/j.jss.2011.03.072] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
225 Hayashi K, Kumada T, Nakano S, Takeda I, Sugiyama K, Kiriyama S, Sone Y, Miyata A, Shimizu H, Satomura S. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Am J Gastroenterol 1999;94:3028-33. [PMID: 10520864 DOI: 10.1111/j.1572-0241.1999.01378.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 44] [Article Influence: 1.5] [Reference Citation Analysis]
226 Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J. A 15-year retrospective study of hepatic resection for stage IV-A hepatocellular carcinoma shows value in hepatitis B negative patients. Am J Surg. 2002;183:89-94. [PMID: 11869711 DOI: 10.1016/S0002-9610(01)00844-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
227 Morimoto M, Numata K, Nozaki A, Tanaka K. Prognosis following non-surgical second treatment in patients with recurrent hepatocellular carcinoma after percutaneous ablation therapy. Liver International 2009;29:443-8. [DOI: 10.1111/j.1478-3231.2008.01890.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
228 Kawamura Y, Ikeda K, Arase Y, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F. Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis. J Gastroenterol Hepatol. 2008;23:1739-1746. [PMID: 18713301 DOI: 10.1111/j.1440-1746.2008.05436.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
229 Santoyo J, Suárez M, Fernández J, Jiménez M, Ramírez C, Pérez Daga A, Bondia J, de la Fuente A. Tratamiento quirúrgico del hepatocarcinoma en el paciente cirrótico: ¿resección o trasplante? Cirugía Española 2001;70:42-8. [DOI: 10.1016/s0009-739x(01)71839-8] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
230 Giorgio A, Tarantino L, de Stefano G, Perrotta A, Aloisio V, del Viscovo L, Alaia A, Lettieri G. Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients. Eur J Ultrasound. 2000;12:145-154. [PMID: 11118922 DOI: 10.1016/s0929-8266(00)00113-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
231 Xu L, Li L, Wang P, Zhang M, Zhang Y, Hao X, Yan L, Li B, Wen T, Xu M. Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single Center. Gut Liver 2019;13:669-82. [PMID: 30970430 DOI: 10.5009/gnl18489] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
232 Kang CM, Choi GH, Kim DH, Choi SB, Kim KS, Choi JS, Lee WJ. Revisiting the role of nonanatomic resection of small (& lt; or = 4 cm) and single hepatocellular carcinoma in patients with well-preserved liver function. J Surg Res. 2010;160:81-89. [PMID: 19577249 DOI: 10.1016/j.jss.2009.01.021] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
233 Liao H, Xiong T, Peng J, Xu L, Liao M, Zhang Z, Wu Z, Yuan K, Zeng Y. Classification and Prognosis Prediction from Histopathological Images of Hepatocellular Carcinoma by a Fully Automated Pipeline Based on Machine Learning. Ann Surg Oncol. 2020;27:2359-2369. [PMID: 31916093 DOI: 10.1245/s10434-019-08190-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
234 Lee HS, Kim KM, Yoon JH, Lee TR, Suh KS, Lee KU, Chung JW, Park JH, Kim CY. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study. J Clin Oncol. 2002;20:4459-4465. [PMID: 12431969 DOI: 10.1200/jco.2002.02.013] [Cited by in Crossref: 86] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
235 Sonohara F, Nomoto S, Inokawa Y, Kanda M, Yamada S, Fujii T, Sugimoto H, Kodera Y. Serosal invasion strongly associated with recurrence after curative hepatic resection of hepatocellular carcinoma: a retrospective study of 214 consecutive cases. Medicine (Baltimore) 2015;94:e602. [PMID: 25738484 DOI: 10.1097/MD.0000000000000602] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
236 Pan MH, Chiou YS, Chen WJ, Wang JM, Badmaev V, Ho CT. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Carcinogenesis 2009;30:1234-42. [PMID: 19447859 DOI: 10.1093/carcin/bgp121] [Cited by in Crossref: 101] [Cited by in F6Publishing: 84] [Article Influence: 8.4] [Reference Citation Analysis]
237 Ikeda Y, Shimada M, Hasegawa H, Gion T, Kajiyama K, Shirabe K, Yanaga K, Takenaka K, Sugimachi K. Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology. 1998;27:1567-1571. [PMID: 9620328 DOI: 10.1002/hep.510270615] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 3.0] [Reference Citation Analysis]
238 Sasaki A, Iwashita Y, Shibata K, Matsumoto T, Ohta M, Kitano S. Improved long-term survival after liver resection for hepatocellular carcinoma in the modern era: retrospective study from HCV-endemic areas. World J Surg. 2006;30:1567-1578. [PMID: 16855807 DOI: 10.1007/s00268-005-0249-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
239 Huo TI, Lui WY, Wu JC, Huang YH, King KL, Loong CC, Lee PC, Chang FY, Lee SD. Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence. World J Surg. 2004;28:258-262. [PMID: 14961198 DOI: 10.1007/s00268-003-7182-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
240 Yu XN, Zhang GC, Sun JL, Zhu HR, Shi X, Song GQ, Weng SQ, Dong L, Liu TT, Shen XZ, Guo HY, Zhu JM. Enhanced mLST8 Expression Correlates with Tumor Progression in Hepatocellular Carcinoma. Ann Surg Oncol 2020;27:1546-57. [PMID: 32157528 DOI: 10.1245/s10434-020-08263-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
241 Fukuda H, Ito R, Ohto M, Sakamoto A, Otsuka M, Togawa A, Miyazaki M, Yamagata H. US-CT 3D dual imaging by mutual display of the same sections for depicting minor changes in hepatocellular carcinoma. European Journal of Radiology 2012;81:2014-9. [DOI: 10.1016/j.ejrad.2011.05.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
242 Liang BY, Gu J, Xiong M, Zhang EL, Zhang ZY, Chen XP, Huang ZY. Tumor size may influence the prognosis of solitary hepatocellular carcinoma patients with cirrhosis and without macrovascular invasion after hepatectomy. Sci Rep 2021;11:16343. [PMID: 34381132 DOI: 10.1038/s41598-021-95835-5] [Reference Citation Analysis]
243 Wang W, Lv J, Chen N, Lou B, Mao W, Wang P, Chen Y. Dysregulated serum metabolites in staging of hepatocellular carcinoma. Clin Biochem 2018;61:7-11. [PMID: 30195484 DOI: 10.1016/j.clinbiochem.2018.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
244 Nagano Y, Shimada H, Takeda K, Ueda M, Matsuo K, Tanaka K, Endo I, Kunisaki C, Togo S. Predictive factors of microvascular invasion in patients with hepatocellular carcinoma larger than 5 cm. World J Surg 2008;32:2218-22. [PMID: 18642045 DOI: 10.1007/s00268-008-9585-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
245 Desautels SG, Slivka A, Schoen RE, Carr B, Rabinovitz M, Silverman W. Gastrointestinal bleeding in cirrhotic patients with hepatocellular carcinoma undergoing intrahepatic artery chemotherapy. Gastrointest Endosc 1997;46:430-4. [PMID: 9402117 DOI: 10.1016/s0016-5107(97)70036-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
246 Kamiyama T, Orimo T, Wakayama K, Shimada S, Nagatsu A, Yokoo H, Kamachi H, Yamashita K, Shimamura T, Taketomi A. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification. World J Surg Oncol 2017;15:156. [PMID: 28830473 DOI: 10.1186/s12957-017-1229-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
247 Lee IJ, Seong J. The optimal selection of radiotherapy treatment for hepatocellular carcinoma. Gut Liver 2012;6:139-48. [PMID: 22570744 DOI: 10.5009/gnl.2012.6.2.139] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
248 Philip PA, Mahoney MR, Allmer C, Thomas J, Pitot HC, Kim G, Donehower RC, Fitch T, Picus J, Erlichman C. Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer. J Clin Oncol. 2005;23:6657-6663. [PMID: 16170173 DOI: 10.1200/jco.2005.14.696] [Cited by in Crossref: 330] [Cited by in F6Publishing: 115] [Article Influence: 20.6] [Reference Citation Analysis]
249 Yamamoto J, Kosuge T, Saiura A, Sakamoto Y, Shimada K, Sano T, Takayama T, Sugawara Y, Yamaguchi T, Kokudo N, Makuuchi M. Effectiveness of Hepatic Resection for Early-stage Hepatocellular Carcinoma in Cirrhotic Patients: Subgroup Analysis according to Milan Criteria. Japanese Journal of Clinical Oncology 2007;37:287-95. [DOI: 10.1093/jjco/hym025] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
250 Spolverato G, Vitale A, Ejaz A, Kim Y, Maithel SK, Cosgrove DP, Pawlik TM. The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma. World J Surg. 2015;39:1474-1484. [PMID: 25665675 DOI: 10.1007/s00268-015-2987-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
251 Esnaola NF, Mirza N, Lauwers GY, Ikai I, Regimbeau JM, Belghiti J, Yamaoka Y, Curley SA, Ellis LM, Nagorney DM. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan. Ann Surg. 2003;238:711-719. [PMID: 14578734 DOI: 10.1097/01.sla.0000094436.34556.ac] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 3.3] [Reference Citation Analysis]
252 Trinchet J, Beaugrand M. Treatment of hepatocellular carcinoma in patients with cirrhosis. Journal of Hepatology 1997;27:756-65. [DOI: 10.1016/s0168-8278(97)80095-5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
253 Yanagida Y, Amano T, Akai R, Toyoshima A, Kobayashi J, Hashimoto T, Sunami E, Kumasaka T, Sasaki S. Treatment of tumor thrombus in the superior mesenteric vein due to advanced colon cancer with complete surgical resection and chemotherapy: a case report. Surg Case Rep 2020;6:320. [PMID: 33315157 DOI: 10.1186/s40792-020-01091-6] [Reference Citation Analysis]
254 Zhang X, Meng B, Qi X, Yu L, Liu C, Liu X, Wang B, Pan C, Lv Y. Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: The surgeon's role in survival. European Journal of Surgical Oncology (EJSO) 2009;35:622-8. [DOI: 10.1016/j.ejso.2008.08.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
255 Bekaii-Saab T, Markowitz J, Prescott N, Sadee W, Heerema N, Wei L, Dai Z, Papp A, Campbell A, Culler K, Balint C, O'Neil B, Lee RM, Zalupski M, Dancey J, Chen H, Grever M, Eng C, Villalona-Calero M. A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas. Clin Cancer Res 2009;15:5895-901. [PMID: 19737952 DOI: 10.1158/1078-0432.CCR-09-0465] [Cited by in Crossref: 73] [Cited by in F6Publishing: 31] [Article Influence: 6.1] [Reference Citation Analysis]
256 Sonohara F, Inokawa Y, Hishida M, Kanda M, Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Kodera Y, Nomoto S. Prognostic significance of AKR1B10 gene expression in hepatocellular carcinoma and surrounding non-tumorous liver tissue. Oncol Lett 2016;12:4821-8. [PMID: 28105190 DOI: 10.3892/ol.2016.5240] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
257 Levy I, Sherman M. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut. 2002;50:881-885. [PMID: 12010894 DOI: 10.1136/gut.50.6.881] [Cited by in Crossref: 171] [Cited by in F6Publishing: 151] [Article Influence: 9.0] [Reference Citation Analysis]
258 Chan AC, Fan ST, Poon RT, Cheung TT, Chok KS, Chan SC, Lo CM. Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system. HPB (Oxford). 2013;15:439-448. [PMID: 23659567 DOI: 10.1111/j.1477-2574.2012.00617.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
259 Pawlik TM, Tseng JF, Vauthey J. Controversies in the Staging of Hepatocellular Carcinoma. Cancer Rev A P 2003;01:179-89. [DOI: 10.1142/s0219836303000220] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]